Long-Term Azithromycin Use for Treatment of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients
Authors:
- David ShitritDSDavid Shitrit
- Daniele BendayanDBDaniele Bendayan
- Sahar GidonSGSahar Gidon
- Milton SauteMSMilton Saute
- Ilana BakalIBIlana Bakal
- Mordechai R. KramerMKMordechai R. Kramer
- 1 September 2005
- journal article
- clinical trial
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (9) , 1440-1443
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Maintenance Azithromycin Therapy for Bronchiolitis Obliterans SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Bronchiolitis Obliterans after Human Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteriaThe Journal of Heart and Lung Transplantation, 2002
- Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trialThorax, 2002
- Effect of Azithromycin on the Severity of Bronchial Hyperresponsiveness in Patients with Mild AsthmaJournal of Asthma, 2002
- Chronic Allograft Rejection (Obliterative Bronchiolitis)Seminars in Respiratory and Critical Care Medicine, 2001
- Features of bronchoalveolar lavage (BAL) in lung transplant recipients (LTR) who later develop bronchiolitis obliterans syndrome (BOS)The Journal of Heart and Lung Transplantation, 2001
- Gastroesophageal Reflux as a Reversible Cause of Allograft Dysfunction After Lung TransplantationChest, 2000
- Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose ErythromycinAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Obliterative bronchiolitis after lung and heart-lung transplantationThe Annals of Thoracic Surgery, 1995